Back to search
FDAFDA · Food and drugs·Recall number D-0876-2017

ceFAZolin sodium added to 100 mL 0.9% Sodium Chloride injectable, 2g, Total Approximate Volume 100 mL, Single Dose Container bag, Preservative Free, Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct. Little Rock, AR 72205, NDC 70004-0522-32

Published June 7, 2017 · Recall initiated: May 18, 2017

Summary

FDA records drug Class II recall D-0876-2017, published June 7, 2017 and initiated May 18, 2017. Recalling firm: SCA Pharmaceuticals; Status: Terminated; Reported quantity: 240 bags; Lot: LOT # 20170510@12, Use By: 06-24-17. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of assurance of sterility: Product bags leaking at seam.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
SCA Pharmaceuticals
Distributor
Nationwide in the USA
Lot
LOT # 20170510@12, Use By: 06-24-17
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was ceFAZolin sodium added to 100 mL 0.9% Sodium Chloride injectable, 2g, Total Approximate Volume 100 mL, Single Dose Container bag, Preservative Free, Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct. Little Rock, AR 72205, NDC 70004-0522-32 recalled?

Yes. FDA published recall D-0876-2017 on June 7, 2017. Reported hazard: Lack of assurance of sterility: Product bags leaking at seam.

What should I do if I have this product?

Voluntary: Firm initiated · Letter